Auris Health, Inc., a pioneering force in the medical technology sector, is headquartered in the United States. Founded in 2007, the company has made significant strides in the development of robotic-assisted surgical systems, particularly in the field of interventional pulmonology. Auris Health is renowned for its innovative products, including the Monarch Platform, which uniquely combines advanced robotics and flexible endoscopy to enhance precision in minimally invasive procedures. With a strong presence in major operational regions across North America and Europe, Auris Health has established itself as a leader in the surgical robotics industry. The company’s commitment to improving patient outcomes and transforming surgical practices has garnered recognition, positioning it as a key player in the evolving landscape of healthcare technology.
How does Auris Health, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Auris Health, Inc.'s score of 78 is higher than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Auris Health, Inc., headquartered in the US, currently does not have specific carbon emissions data available for reporting. The company is a current subsidiary of Johnson & Johnson, which cascades its climate commitments and emissions data. As part of this corporate family, Auris Health aligns with Johnson & Johnson's sustainability initiatives, including their Science Based Targets initiative (SBTi) commitments and other climate-related pledges. While specific reduction targets for Auris Health are not detailed, the overarching goals set by Johnson & Johnson include significant efforts to reduce greenhouse gas emissions across all scopes. This includes initiatives aimed at achieving net-zero emissions in their operations and supply chain, reflecting a strong commitment to climate action. As of now, Auris Health's climate strategy is integrated within the broader framework established by Johnson & Johnson, which focuses on sustainable practices and reducing environmental impact. The absence of specific emissions data highlights the need for ongoing transparency and commitment to climate goals within the medical technology sector.
Access structured emissions data, company-specific emission factors, and source documents
| 1990 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 308,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 751,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | - | - | 00,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Auris Health, Inc.'s Scope 3 emissions, which decreased by 2% last year and increased significantly since 2011, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 72% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Auris Health, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.